RESEARCH AND DEVELOPMENT EXPENSES

12 Months Ended

Dec. 31, 2020

NOTE 21 - RESEARCH AND DEVELOPMENT EXPENSES

Research and development expenses, excluding stock-based compensation and depreciation expenses, allocated to our major research and development programs are as follows:

In Thousands of US Dollars
	For the Year Ended December 31,
Research and Development Program	2020		2019		2018
Research and Development Program	$	-	$	4	$	2
Alzheimer’s Disease: Therapeutics		-		4		-
Anti-Infectives		4		4		4
BPH (Enlarged Prostate) and Prostate Cancer Therapeutics		7,162		5,932		4,917
Tobacco Exposure Tests: NicAlert™ and TobacAlert™		1		18		2
Total	$	7,167	$	5,962	$	4,925